Ken/Pro - what's going to happen to EXAS when SQNM announces a test to detect cancer based on methylation markers in plasma? Do you think CRC could be a candidate? What happens to SQNM's stock when that headline hits the wires? First things first with the prenatal business but cancer won't be far behind. It was news at the analyst day presentation that methylation markers were used to detect aneuploidies for the first time so now we know they're perfecting the technology. SQNM has the rights and what better way to detect cancer - a simple blood test - no poop. It's no wonder SQNM scares the crap out of you.
From Dr. Lo's bio...
1999: First discovery of the presence of cancer-derived DNA methylation changes in plasma. This discovery has opened up a new class of tumour markers.
• 1999: First development of a rapid method for the analysis of DNA methylation. This method can be used for measuring this important molecular change which is associated with a number of diseases, including cancer.
Rosetta Genomics (ROSG) announced the development of a blood serum based test for colon cancer utilizing microRNA biomarkers last month. They are expected to announce soon the development of a similar test for lung cancer.